Economists at Westpac believe coronavirus vaccines will eliminate downside risks for the US economy which is set to rebound strongly in 2021. What’s more, FOMC is set to maintain extraordinary support.
Key quotes
“If we look ahead a year to the end of 2021, by then the US economy should not only have recouped the remainder of 2020’s GDP loss but improved on the December 2019 level – likely by a percentage point. Annualised growth between October 2020 and December 2021 roughly twice the rate of potential should also see a further material decline in the unemployment rate – likely to around 5% – and a similar improvement in underemployment as hours worked are brought back to more normal levels.”
“By the end of 2022, US GDP is forecast to be 4ppts higher than end-2019, in effect regaining two-thirds of the gain that would have been seen had the pandemic not occurred, assuming potential growth of roughly 2% per year. At that juncture, the unemployment rate is likely to be down near 4% and underemployment back towards pre-pandemic levels.”
“To the downside, the primary concerns are around the distribution and take-up of vaccines and their longevity. As long as vaccines are taken and provide protection for six months or more, the risk of a COVID-19 resurgence should be extremely low. However, if we see disappointment on either or both fronts, uncertainty and restrictions on economic activity could persist for a protracted period.”
“One risk that seems improbable is the FOMC choosing to ratchet back their extraordinary support for the economy too soon, hampering the recovery. The structural disappointment on inflation as well as the near-term economic risks the US still faces lead us to believe that the FOMC should provide additional easing at their December 2020 meeting, as the ECB did last week, and keep forward guidance in 2021 focused on the need for an extended period of ultra-accommodative policy. Policy can always be tightened in response to an upside surprise. However, economic confidence and trust are not easily won back after successive disappointments.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD treads water just above 1.0400 post-US data
Another sign of the good health of the US economy came in response to firm flash US Manufacturing and Services PMIs, which in turn reinforced further the already strong performance of the US Dollar, relegating EUR/USD to the 1.0400 neighbourhood on Friday.
GBP/USD remains depressed near 1.2520 on stronger Dollar
Poor results from the UK docket kept the British pound on the back foot on Thursday, hovering around the low-1.2500s in a context of generalized weakness in the risk-linked galaxy vs. another outstanding day in the Greenback.
Gold keeps the bid bias unchanged near $2,700
Persistent safe haven demand continues to prop up the march north in Gold prices so far on Friday, hitting new two-week tops past the key $2,700 mark per troy ounce despite extra strength in the Greenback and mixed US yields.
Geopolitics back on the radar
Rising tensions between Russia and Ukraine caused renewed unease in the markets this week. Putin signed an amendment to Russian nuclear doctrine, which allows Russia to use nuclear weapons for retaliating against strikes carried out with conventional weapons.
Eurozone PMI sounds the alarm about growth once more
The composite PMI dropped from 50 to 48.1, once more stressing growth concerns for the eurozone. Hard data has actually come in better than expected recently – so ahead of the December meeting, the ECB has to figure out whether this is the PMI crying wolf or whether it should take this signal seriously. We think it’s the latter.
Best Forex Brokers with Low Spreads
VERIFIED Low spreads are crucial for reducing trading costs. Explore top Forex brokers offering competitive spreads and high leverage. Compare options for EUR/USD, GBP/USD, USD/JPY, and Gold.